Abstract

Fibromyalgia is a painful and chronic syndrome that causes disabling pain, that involve conditions like anxiety, depression, mood changes, sleep disorders, irritable bowel, among other changes. Chronic pain is directly correlated with high blood pressure; also, pain can generate changes in both blood pressure and intracranial pressure. There are several treatments for fibromyalgia, where Photonic Treatment, which combines photobiostimulation and ultrasound, promotes a new treatment approach, applied to the palms of the hands, enabling systemic action. The intracranial assessment patient was measured aiming possible intracranial changes, according to compliance in the study of intracranial assessment of pressure study, developed by Braincare and Innovation SA. The results were evaluated before and after the photosonic treatment. They were carried out through large estimates, monitoring scale non-invasive intracranial by analysis variables Braincare and Innovation SA. The results show an evolution in the Visual Analogue Scale, indicating a reduction in intracranial pressure (-70%) and in the Fibromyalgia Impact Questionnaire, indicating a reduction in pain (-60.4%), where inversely proportional, it indicates an improvement in quality of life. The distribution of the P2 × P1, a time relationship for each session performed an entropy found in the BPM analysis before treatment, showed significantly different. Thus, this study found variations in intracranial pressure through the action of photosonic treatment, pointing to a significant improvement in the patient's general condition after applications, relating variations in intracranial pressure with possible changes relevant to the disease. Although these results are important and guide new actions, more studies need to be carried out.